Modulation of hormone signaling

"Modulation of hormone signaling" refers to a broad category of therapeutic interventions aimed at adjusting or interfering with the action of hormones, often by targeting hormone receptors, signaling intermediates, or downstream transcriptional events. This process is relevant to a variety of diseases, including cancers, metabolic, and endocrine disorders. There is no single molecule or canonical receptor described by this term; rather, it encompasses a class of diverse molecular targets such as G protein-coupled receptors, nuclear hormone receptors (e.g., estrogen, androgen, glucocorticoid receptors), kinases involved in downstream signaling, and enzymes involved in hormone biosynthesis[1][2][4][5][8][9][10]. Drugs that modulate hormone signaling include receptor antagonists (e.g., anti-estrogens), hormone synthesis inhibitors, and pathway-specific inhibitors. Selection of appropriate interventions and monitoring rely on accurate identification of the specific hormone signaling axis involved in the disease state. In summary, "modulation of hormone signaling" is not a specific therapeutic target but defines a mechanism category involving multiple identified targets, receptors, and signaling entities across hormone-regulated biological systems.